| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Pancreatic Neoplasms | 20 | 2025 | 738 | 1.910 |
Why?
|
| Adenocarcinoma | 9 | 2025 | 1071 | 1.010 |
Why?
|
| Genome, Human | 9 | 2025 | 1351 | 0.770 |
Why?
|
| Sequence Analysis, DNA | 7 | 2021 | 1837 | 0.750 |
Why?
|
| Transplants | 1 | 2021 | 37 | 0.710 |
Why?
|
| Biomarkers, Tumor | 7 | 2025 | 1721 | 0.660 |
Why?
|
| Mutation | 13 | 2025 | 6338 | 0.640 |
Why?
|
| Carcinoma, Pancreatic Ductal | 4 | 2025 | 167 | 0.620 |
Why?
|
| Receptors, Somatostatin | 4 | 2011 | 56 | 0.600 |
Why?
|
| Organ Transplantation | 1 | 2021 | 186 | 0.600 |
Why?
|
| Ampulla of Vater | 3 | 2025 | 17 | 0.600 |
Why?
|
| Central Nervous System Neoplasms | 1 | 2021 | 216 | 0.590 |
Why?
|
| Duodenal Neoplasms | 1 | 2016 | 23 | 0.500 |
Why?
|
| Proto-Oncogene Proteins c-ets | 1 | 2016 | 59 | 0.480 |
Why?
|
| Common Bile Duct Neoplasms | 2 | 2025 | 10 | 0.470 |
Why?
|
| Bile Duct Neoplasms | 3 | 2023 | 121 | 0.460 |
Why?
|
| Cholangiocarcinoma | 3 | 2023 | 121 | 0.460 |
Why?
|
| Wnt Signaling Pathway | 1 | 2016 | 207 | 0.450 |
Why?
|
| Protein Tyrosine Phosphatases, Non-Receptor | 2 | 2016 | 20 | 0.440 |
Why?
|
| Gene Expression Profiling | 5 | 2015 | 1923 | 0.400 |
Why?
|
| Genomics | 7 | 2025 | 1681 | 0.360 |
Why?
|
| DNA-Binding Proteins | 4 | 2022 | 2178 | 0.330 |
Why?
|
| Carcinoma, Hepatocellular | 4 | 2014 | 1007 | 0.320 |
Why?
|
| Sequence Analysis, Protein | 1 | 2009 | 49 | 0.310 |
Why?
|
| AMP-Activated Protein Kinases | 3 | 2015 | 182 | 0.300 |
Why?
|
| Carcinoma, Neuroendocrine | 2 | 2021 | 39 | 0.300 |
Why?
|
| Liver Neoplasms | 5 | 2017 | 1417 | 0.300 |
Why?
|
| Genetic Techniques | 1 | 2009 | 109 | 0.300 |
Why?
|
| Gene Expression Regulation, Neoplastic | 13 | 2020 | 2137 | 0.290 |
Why?
|
| Gene Library | 1 | 2009 | 225 | 0.290 |
Why?
|
| Transcription Factors | 4 | 2017 | 2738 | 0.280 |
Why?
|
| Polymorphism, Single Nucleotide | 4 | 2011 | 2947 | 0.280 |
Why?
|
| Musculoskeletal Abnormalities | 2 | 2022 | 72 | 0.280 |
Why?
|
| PTEN Phosphohydrolase | 1 | 2009 | 262 | 0.270 |
Why?
|
| Tumor Suppressor Proteins | 5 | 2020 | 510 | 0.270 |
Why?
|
| Tissue Banks | 3 | 2011 | 30 | 0.260 |
Why?
|
| Pain Threshold | 1 | 2006 | 23 | 0.250 |
Why?
|
| Homeodomain Proteins | 5 | 2016 | 589 | 0.240 |
Why?
|
| Base Sequence | 9 | 2017 | 3180 | 0.240 |
Why?
|
| Laminin | 1 | 2006 | 72 | 0.240 |
Why?
|
| Dermatologic Surgical Procedures | 1 | 2006 | 41 | 0.240 |
Why?
|
| Humans | 55 | 2025 | 134156 | 0.240 |
Why?
|
| Neoplasm Proteins | 4 | 2009 | 719 | 0.240 |
Why?
|
| Strepsirhini | 1 | 2025 | 2 | 0.240 |
Why?
|
| Nerve Regeneration | 1 | 2006 | 85 | 0.240 |
Why?
|
| Precision Medicine | 3 | 2015 | 357 | 0.230 |
Why?
|
| Proto-Oncogene Proteins | 3 | 2015 | 625 | 0.230 |
Why?
|
| Intellectual Disability | 3 | 2022 | 1091 | 0.230 |
Why?
|
| Trans-Activators | 5 | 2016 | 840 | 0.230 |
Why?
|
| RNA, Messenger | 11 | 2017 | 2915 | 0.230 |
Why?
|
| Integrins | 5 | 2016 | 103 | 0.230 |
Why?
|
| Cell Line, Tumor | 12 | 2025 | 3798 | 0.220 |
Why?
|
| Genetic Predisposition to Disease | 6 | 2021 | 3506 | 0.220 |
Why?
|
| Tissue Engineering | 1 | 2006 | 184 | 0.220 |
Why?
|
| Antigens, CD | 3 | 2001 | 451 | 0.220 |
Why?
|
| U937 Cells | 2 | 2001 | 25 | 0.210 |
Why?
|
| Gene Flow | 1 | 2023 | 15 | 0.210 |
Why?
|
| Molecular Sequence Data | 7 | 2016 | 3980 | 0.210 |
Why?
|
| DNA Mutational Analysis | 3 | 2021 | 843 | 0.210 |
Why?
|
| Papio | 1 | 2023 | 60 | 0.210 |
Why?
|
| Receptors, Cell Surface | 4 | 2009 | 497 | 0.200 |
Why?
|
| Polymerase Chain Reaction | 7 | 2012 | 1627 | 0.200 |
Why?
|
| Hematopoietic Stem Cells | 3 | 2002 | 564 | 0.200 |
Why?
|
| Monocytes | 2 | 2002 | 360 | 0.200 |
Why?
|
| Skin | 1 | 2006 | 545 | 0.200 |
Why?
|
| Fibroblasts | 3 | 2006 | 928 | 0.200 |
Why?
|
| Genes, Neoplasm | 2 | 2016 | 91 | 0.190 |
Why?
|
| Databases, Genetic | 3 | 2016 | 507 | 0.190 |
Why?
|
| Neoplasms | 3 | 2016 | 3038 | 0.190 |
Why?
|
| Proteomics | 1 | 2006 | 599 | 0.190 |
Why?
|
| Biological Evolution | 1 | 2023 | 256 | 0.190 |
Why?
|
| Precursor B-Cell Lymphoblastic Leukemia-Lymphoma | 1 | 2003 | 146 | 0.190 |
Why?
|
| Lectins, C-Type | 1 | 2002 | 74 | 0.190 |
Why?
|
| Lung Neoplasms | 7 | 2015 | 1787 | 0.190 |
Why?
|
| Receptors, IgE | 1 | 2001 | 11 | 0.180 |
Why?
|
| Membrane Glycoproteins | 2 | 2002 | 433 | 0.180 |
Why?
|
| Antigens, CD20 | 1 | 2001 | 40 | 0.180 |
Why?
|
| Carcinoma, Non-Small-Cell Lung | 2 | 2015 | 377 | 0.180 |
Why?
|
| Receptors, Immunologic | 1 | 2002 | 128 | 0.180 |
Why?
|
| Hyperglycemia | 1 | 2023 | 242 | 0.180 |
Why?
|
| INDEL Mutation | 1 | 2021 | 94 | 0.180 |
Why?
|
| Glioblastoma | 2 | 1995 | 375 | 0.180 |
Why?
|
| Cell Movement | 4 | 2020 | 920 | 0.170 |
Why?
|
| Genotype | 3 | 2011 | 2814 | 0.170 |
Why?
|
| Prognosis | 5 | 2025 | 5086 | 0.170 |
Why?
|
| Animals | 31 | 2025 | 36557 | 0.170 |
Why?
|
| B-Lymphocytes | 1 | 2003 | 551 | 0.170 |
Why?
|
| DNA, Neoplasm | 2 | 2016 | 320 | 0.160 |
Why?
|
| Antigens, Differentiation, Myelomonocytic | 1 | 2000 | 38 | 0.160 |
Why?
|
| Genes, Dominant | 1 | 2020 | 253 | 0.160 |
Why?
|
| Precursor Cell Lymphoblastic Leukemia-Lymphoma | 2 | 2005 | 820 | 0.160 |
Why?
|
| Endosomal Sorting Complexes Required for Transport | 2 | 2016 | 26 | 0.160 |
Why?
|
| Cell Adhesion Molecules | 3 | 1995 | 256 | 0.160 |
Why?
|
| Transplant Recipients | 1 | 2021 | 227 | 0.160 |
Why?
|
| Esophageal Neoplasms | 1 | 2024 | 396 | 0.160 |
Why?
|
| Transfection | 7 | 2010 | 1096 | 0.150 |
Why?
|
| Patient Selection | 2 | 2020 | 735 | 0.150 |
Why?
|
| STAT3 Transcription Factor | 1 | 2020 | 231 | 0.150 |
Why?
|
| Mice | 22 | 2016 | 19055 | 0.150 |
Why?
|
| DNA Methylation | 3 | 2021 | 1148 | 0.150 |
Why?
|
| Abnormalities, Multiple | 2 | 2022 | 979 | 0.140 |
Why?
|
| NF-kappa B | 1 | 2020 | 482 | 0.140 |
Why?
|
| Endothelium, Vascular | 3 | 1997 | 522 | 0.140 |
Why?
|
| Tissue Donors | 1 | 2021 | 523 | 0.140 |
Why?
|
| Male | 19 | 2025 | 66127 | 0.140 |
Why?
|
| Biopsy | 1 | 2021 | 1304 | 0.140 |
Why?
|
| Genetic Testing | 2 | 2021 | 1099 | 0.130 |
Why?
|
| Neurodevelopmental Disorders | 1 | 2022 | 545 | 0.130 |
Why?
|
| Adenovirus E3 Proteins | 1 | 1996 | 3 | 0.130 |
Why?
|
| Islets of Langerhans | 3 | 2012 | 178 | 0.130 |
Why?
|
| Isocitrate Dehydrogenase | 1 | 2017 | 84 | 0.130 |
Why?
|
| Phosphoenolpyruvate Carboxykinase (ATP) | 1 | 2015 | 7 | 0.120 |
Why?
|
| Osmoregulation | 1 | 2015 | 2 | 0.120 |
Why?
|
| Caenorhabditis elegans | 2 | 2015 | 245 | 0.120 |
Why?
|
| Amino Acid Sequence | 3 | 2009 | 2795 | 0.120 |
Why?
|
| Integrin alpha5beta1 | 1 | 2015 | 6 | 0.120 |
Why?
|
| Adenoviruses, Human | 1 | 1996 | 99 | 0.120 |
Why?
|
| Cardiology | 1 | 2021 | 521 | 0.120 |
Why?
|
| Glycogen | 1 | 2015 | 65 | 0.120 |
Why?
|
| DNA, Complementary | 2 | 2009 | 472 | 0.120 |
Why?
|
| Phosphotransferases (Alcohol Group Acceptor) | 1 | 2016 | 79 | 0.120 |
Why?
|
| Epigenesis, Genetic | 1 | 2021 | 773 | 0.120 |
Why?
|
| Endosomes | 1 | 2015 | 68 | 0.120 |
Why?
|
| Cells, Cultured | 4 | 2006 | 3188 | 0.120 |
Why?
|
| Brain Neoplasms | 2 | 1995 | 1409 | 0.120 |
Why?
|
| Macrophages | 1 | 2000 | 711 | 0.120 |
Why?
|
| Microsatellite Repeats | 1 | 2016 | 241 | 0.120 |
Why?
|
| Gluconeogenesis | 1 | 2015 | 111 | 0.120 |
Why?
|
| Gene Expression | 1 | 2000 | 1621 | 0.120 |
Why?
|
| Cell Line | 6 | 2014 | 2864 | 0.120 |
Why?
|
| Neutrophils | 1 | 1997 | 402 | 0.120 |
Why?
|
| Diabetes Mellitus | 1 | 2023 | 937 | 0.120 |
Why?
|
| Female | 15 | 2025 | 71928 | 0.110 |
Why?
|
| Ubiquitination | 1 | 2015 | 186 | 0.110 |
Why?
|
| Brain Chemistry | 1 | 1995 | 125 | 0.110 |
Why?
|
| Oncogenes | 4 | 2010 | 181 | 0.110 |
Why?
|
| Sequence Homology, Amino Acid | 2 | 2009 | 673 | 0.110 |
Why?
|
| Haploinsufficiency | 1 | 2016 | 274 | 0.110 |
Why?
|
| Estrone | 1 | 2014 | 13 | 0.110 |
Why?
|
| Cell Proliferation | 7 | 2023 | 2563 | 0.110 |
Why?
|
| Fibrosarcoma | 3 | 1990 | 26 | 0.110 |
Why?
|
| Genomic Instability | 1 | 2016 | 248 | 0.110 |
Why?
|
| Mice, Nude | 3 | 2016 | 780 | 0.110 |
Why?
|
| Spermatozoa | 1 | 1996 | 251 | 0.110 |
Why?
|
| Phenotype | 6 | 2023 | 4598 | 0.100 |
Why?
|
| Adult | 6 | 2025 | 31945 | 0.100 |
Why?
|
| Oligonucleotide Array Sequence Analysis | 2 | 2009 | 1071 | 0.100 |
Why?
|
| Genes, ras | 2 | 1990 | 102 | 0.100 |
Why?
|
| Middle Aged | 5 | 2025 | 29399 | 0.100 |
Why?
|
| Membrane Proteins | 4 | 2020 | 1622 | 0.100 |
Why?
|
| RNA Interference | 2 | 2012 | 548 | 0.100 |
Why?
|
| Neoplasm Invasiveness | 4 | 2020 | 675 | 0.100 |
Why?
|
| Insulinoma | 1 | 2012 | 10 | 0.100 |
Why?
|
| Genes, Tumor Suppressor | 2 | 2014 | 225 | 0.100 |
Why?
|
| Molecular Targeted Therapy | 1 | 2015 | 407 | 0.100 |
Why?
|
| Genetic Vectors | 1 | 1996 | 970 | 0.100 |
Why?
|
| Pedigree | 3 | 2025 | 1728 | 0.090 |
Why?
|
| Antibodies, Monoclonal, Murine-Derived | 1 | 2011 | 63 | 0.090 |
Why?
|
| Proto-Oncogene Proteins p21(ras) | 2 | 2012 | 178 | 0.090 |
Why?
|
| National Cancer Institute (U.S.) | 1 | 2011 | 34 | 0.090 |
Why?
|
| Nucleic Acid Hybridization | 3 | 2003 | 397 | 0.090 |
Why?
|
| Glucose | 3 | 2023 | 927 | 0.090 |
Why?
|
| Neuroendocrine Tumors | 1 | 2011 | 56 | 0.090 |
Why?
|
| Somatostatin | 1 | 2011 | 69 | 0.090 |
Why?
|
| Histone Acetyltransferases | 1 | 2012 | 319 | 0.090 |
Why?
|
| Neoplasm Metastasis | 3 | 1990 | 746 | 0.090 |
Why?
|
| Lymphocytes, Tumor-Infiltrating | 3 | 1996 | 145 | 0.090 |
Why?
|
| Autophagy | 1 | 2014 | 429 | 0.090 |
Why?
|
| Reverse Transcriptase Polymerase Chain Reaction | 4 | 2011 | 1332 | 0.090 |
Why?
|
| Patient Care | 1 | 2011 | 101 | 0.080 |
Why?
|
| DNA | 1 | 1996 | 1682 | 0.080 |
Why?
|
| Guidelines as Topic | 1 | 2011 | 203 | 0.080 |
Why?
|
| Epigenomics | 3 | 2021 | 196 | 0.080 |
Why?
|
| Dystonic Disorders | 1 | 2011 | 94 | 0.080 |
Why?
|
| Endopeptidases | 1 | 1990 | 119 | 0.080 |
Why?
|
| Urogenital Abnormalities | 1 | 2012 | 164 | 0.080 |
Why?
|
| Aged, 80 and over | 3 | 2025 | 7217 | 0.080 |
Why?
|
| Axons | 1 | 2012 | 397 | 0.080 |
Why?
|
| Genome | 1 | 2012 | 528 | 0.080 |
Why?
|
| Inteins | 1 | 2009 | 3 | 0.080 |
Why?
|
| DNA Primers | 2 | 2003 | 672 | 0.080 |
Why?
|
| DNA Fragmentation | 1 | 2009 | 61 | 0.080 |
Why?
|
| Cell Transformation, Neoplastic | 5 | 2014 | 645 | 0.080 |
Why?
|
| Cytokines | 1 | 1995 | 1401 | 0.080 |
Why?
|
| Cell Differentiation | 3 | 2002 | 2045 | 0.080 |
Why?
|
| Extracellular Matrix | 1 | 1990 | 251 | 0.080 |
Why?
|
| Catalysis | 1 | 2009 | 138 | 0.080 |
Why?
|
| Nucleic Acid Amplification Techniques | 1 | 2009 | 72 | 0.080 |
Why?
|
| Oxidative Stress | 1 | 2014 | 877 | 0.070 |
Why?
|
| Risk | 1 | 2011 | 837 | 0.070 |
Why?
|
| Cardiovascular Diseases | 1 | 2021 | 2090 | 0.070 |
Why?
|
| Conserved Sequence | 1 | 2009 | 300 | 0.070 |
Why?
|
| ras Proteins | 1 | 2009 | 146 | 0.070 |
Why?
|
| Pharmacogenetics | 2 | 2021 | 197 | 0.070 |
Why?
|
| Kinetics | 2 | 2009 | 1357 | 0.070 |
Why?
|
| Nuclear Proteins | 3 | 2020 | 1351 | 0.070 |
Why?
|
| Young Adult | 1 | 2021 | 9944 | 0.070 |
Why?
|
| Proportional Hazards Models | 1 | 2011 | 1488 | 0.070 |
Why?
|
| Aged | 4 | 2025 | 21775 | 0.060 |
Why?
|
| Alleles | 1 | 2011 | 1724 | 0.060 |
Why?
|
| Exons | 1 | 2009 | 839 | 0.060 |
Why?
|
| Skin, Artificial | 1 | 2006 | 8 | 0.060 |
Why?
|
| Liver | 6 | 2017 | 1879 | 0.060 |
Why?
|
| Mitochondria | 3 | 2017 | 757 | 0.060 |
Why?
|
| Immunohistochemistry | 4 | 2012 | 1765 | 0.060 |
Why?
|
| Up-Regulation | 3 | 2010 | 915 | 0.060 |
Why?
|
| Neoplasm Transplantation | 3 | 2012 | 399 | 0.060 |
Why?
|
| Adolescent | 3 | 2021 | 20624 | 0.060 |
Why?
|
| Gene Expression Regulation, Leukemic | 1 | 2005 | 69 | 0.060 |
Why?
|
| RNA-Binding Proteins | 2 | 2022 | 622 | 0.060 |
Why?
|
| Madagascar | 1 | 2025 | 2 | 0.060 |
Why?
|
| Papio anubis | 1 | 2025 | 4 | 0.060 |
Why?
|
| Antineoplastic Agents | 1 | 2015 | 1853 | 0.060 |
Why?
|
| Smoking | 1 | 2011 | 1136 | 0.060 |
Why?
|
| Mice, SCID | 3 | 2012 | 615 | 0.060 |
Why?
|
| Mutation Rate | 1 | 2025 | 72 | 0.060 |
Why?
|
| alpha-Fetoproteins | 4 | 1988 | 134 | 0.060 |
Why?
|
| Apoptosis | 3 | 2014 | 1946 | 0.060 |
Why?
|
| Chemotherapy, Adjuvant | 1 | 2025 | 401 | 0.050 |
Why?
|
| Subtraction Technique | 1 | 2003 | 36 | 0.050 |
Why?
|
| Signal Transduction | 4 | 2015 | 4934 | 0.050 |
Why?
|
| Exome | 3 | 2014 | 1087 | 0.050 |
Why?
|
| Whole Genome Sequencing | 1 | 2025 | 325 | 0.050 |
Why?
|
| Baclofen | 1 | 2023 | 45 | 0.050 |
Why?
|
| Glycogen Synthase Kinase 3 | 1 | 2023 | 66 | 0.050 |
Why?
|
| RNA, Neoplasm | 1 | 2003 | 146 | 0.050 |
Why?
|
| TOR Serine-Threonine Kinases | 2 | 2017 | 456 | 0.050 |
Why?
|
| Carcinogenesis | 2 | 2016 | 364 | 0.050 |
Why?
|
| Bile Ducts, Intrahepatic | 1 | 2023 | 105 | 0.050 |
Why?
|
| Qa-SNARE Proteins | 1 | 2022 | 20 | 0.050 |
Why?
|
| Integrin beta1 | 3 | 1997 | 56 | 0.050 |
Why?
|
| Sphingomyelin Phosphodiesterase | 1 | 2022 | 43 | 0.050 |
Why?
|
| Case-Control Studies | 2 | 2003 | 3668 | 0.050 |
Why?
|
| Triggering Receptor Expressed on Myeloid Cells-1 | 1 | 2002 | 2 | 0.050 |
Why?
|
| Species Specificity | 1 | 2023 | 571 | 0.050 |
Why?
|
| Wound Healing | 1 | 2006 | 488 | 0.050 |
Why?
|
| Endoribonucleases | 1 | 2022 | 85 | 0.050 |
Why?
|
| beta Catenin | 1 | 2023 | 232 | 0.050 |
Why?
|
| Reactive Oxygen Species | 2 | 2016 | 535 | 0.050 |
Why?
|
| Phosphoprotein Phosphatases | 1 | 2022 | 127 | 0.050 |
Why?
|
| Immune Evasion | 1 | 2021 | 36 | 0.050 |
Why?
|
| Pharmacogenomic Testing | 1 | 2021 | 40 | 0.050 |
Why?
|
| src-Family Kinases | 1 | 2002 | 97 | 0.050 |
Why?
|
| Cloning, Molecular | 2 | 2001 | 912 | 0.040 |
Why?
|
| Sex Characteristics | 1 | 2023 | 338 | 0.040 |
Why?
|
| Acetyltransferases | 2 | 2000 | 92 | 0.040 |
Why?
|
| Leukemia, Myeloid | 1 | 2001 | 83 | 0.040 |
Why?
|
| Databases, Nucleic Acid | 2 | 2011 | 74 | 0.040 |
Why?
|
| Tumor Cells, Cultured | 2 | 2001 | 1107 | 0.040 |
Why?
|
| Peru | 1 | 2020 | 56 | 0.040 |
Why?
|
| Tissue Distribution | 1 | 2001 | 402 | 0.040 |
Why?
|
| Phylogeny | 1 | 2023 | 785 | 0.040 |
Why?
|
| Mice, Inbred C57BL | 3 | 2016 | 4879 | 0.040 |
Why?
|
| Mediator Complex | 1 | 2020 | 57 | 0.040 |
Why?
|
| Tumor Burden | 1 | 2021 | 259 | 0.040 |
Why?
|
| Independent Living | 1 | 2020 | 71 | 0.040 |
Why?
|
| Lipopolysaccharide Receptors | 1 | 2000 | 53 | 0.040 |
Why?
|
| Neoplasm Grading | 1 | 2021 | 307 | 0.040 |
Why?
|
| Interleukin-1beta | 1 | 2020 | 167 | 0.040 |
Why?
|
| Viral Proteins | 1 | 2002 | 360 | 0.040 |
Why?
|
| Blotting, Southern | 1 | 2000 | 221 | 0.040 |
Why?
|
| Pancreas | 2 | 2012 | 232 | 0.040 |
Why?
|
| Forecasting | 2 | 2011 | 377 | 0.040 |
Why?
|
| Blotting, Northern | 1 | 2000 | 272 | 0.040 |
Why?
|
| Antigens, CD34 | 1 | 2000 | 112 | 0.040 |
Why?
|
| Retrospective Studies | 2 | 2024 | 17540 | 0.040 |
Why?
|
| Tumor Suppressor Protein p53 | 2 | 2016 | 797 | 0.040 |
Why?
|
| United States | 4 | 2021 | 11763 | 0.040 |
Why?
|
| Promoter Regions, Genetic | 2 | 2017 | 1433 | 0.040 |
Why?
|
| Protein Transport | 2 | 2015 | 390 | 0.040 |
Why?
|
| Adenoviridae | 1 | 2002 | 609 | 0.040 |
Why?
|
| Leukemia | 1 | 2002 | 379 | 0.040 |
Why?
|
| Antigens, Tumor-Associated, Carbohydrate | 2 | 1995 | 12 | 0.040 |
Why?
|
| Mice, Inbred mdx | 1 | 1998 | 46 | 0.040 |
Why?
|
| Intercellular Adhesion Molecule-1 | 2 | 1996 | 149 | 0.040 |
Why?
|
| Colorectal Neoplasms | 1 | 2024 | 652 | 0.040 |
Why?
|
| Running | 1 | 1998 | 34 | 0.040 |
Why?
|
| Adaptor Proteins, Signal Transducing | 1 | 2002 | 628 | 0.040 |
Why?
|
| Acute Disease | 1 | 2001 | 1192 | 0.040 |
Why?
|
| Integrin alpha6beta1 | 1 | 1997 | 2 | 0.040 |
Why?
|
| N-Formylmethionine Leucyl-Phenylalanine | 1 | 1997 | 10 | 0.040 |
Why?
|
| Reference Values | 2 | 1998 | 741 | 0.040 |
Why?
|
| Cell Degranulation | 1 | 1997 | 31 | 0.030 |
Why?
|
| Family | 1 | 2020 | 593 | 0.030 |
Why?
|
| Alternative Splicing | 1 | 2000 | 378 | 0.030 |
Why?
|
| RNA, Small Interfering | 2 | 2010 | 721 | 0.030 |
Why?
|
| RNA-Binding Protein EWS | 1 | 2017 | 37 | 0.030 |
Why?
|
| DNA Glycosylases | 1 | 2017 | 33 | 0.030 |
Why?
|
| Calmodulin-Binding Proteins | 1 | 2017 | 65 | 0.030 |
Why?
|
| Plasmids | 2 | 1996 | 529 | 0.030 |
Why?
|
| Insulin | 2 | 2012 | 1260 | 0.030 |
Why?
|
| Salmon | 1 | 1996 | 5 | 0.030 |
Why?
|
| Hemizygote | 1 | 2016 | 13 | 0.030 |
Why?
|
| Interleukin-8 | 1 | 1997 | 221 | 0.030 |
Why?
|
| Avian Sarcoma Viruses | 1 | 1996 | 31 | 0.030 |
Why?
|
| Proton-Translocating ATPases | 1 | 1996 | 18 | 0.030 |
Why?
|
| Hepatocyte Nuclear Factor 3-gamma | 1 | 2016 | 4 | 0.030 |
Why?
|
| Thymidine Kinase | 1 | 1996 | 95 | 0.030 |
Why?
|
| Chromatin Assembly and Disassembly | 1 | 2017 | 124 | 0.030 |
Why?
|
| Hepatocyte Nuclear Factor 3-beta | 1 | 2016 | 28 | 0.030 |
Why?
|
| Prolactin | 1 | 1996 | 116 | 0.030 |
Why?
|
| Phosphoenolpyruvate | 1 | 2015 | 2 | 0.030 |
Why?
|
| Glycogen Phosphorylase | 1 | 2015 | 1 | 0.030 |
Why?
|
| Glycogen Synthase | 1 | 2015 | 7 | 0.030 |
Why?
|
| Sequence Homology, Nucleic Acid | 1 | 1996 | 295 | 0.030 |
Why?
|
| Transcription, Genetic | 3 | 2016 | 1761 | 0.030 |
Why?
|
| Access to Information | 1 | 2016 | 44 | 0.030 |
Why?
|
| Cricetulus | 1 | 2015 | 97 | 0.030 |
Why?
|
| Histone Demethylases | 1 | 2016 | 44 | 0.030 |
Why?
|
| Biological Specimen Banks | 1 | 2016 | 55 | 0.030 |
Why?
|
| Th2 Cells | 1 | 1996 | 190 | 0.030 |
Why?
|
| Osmolar Concentration | 1 | 2015 | 179 | 0.030 |
Why?
|
| Citric Acid Cycle | 1 | 2015 | 49 | 0.030 |
Why?
|
| CHO Cells | 1 | 2015 | 167 | 0.030 |
Why?
|
| Pyruvic Acid | 1 | 2015 | 39 | 0.030 |
Why?
|
| CD58 Antigens | 1 | 1995 | 7 | 0.030 |
Why?
|
| Receptors, Lymphocyte Homing | 1 | 1995 | 20 | 0.030 |
Why?
|
| Purines | 1 | 2015 | 119 | 0.030 |
Why?
|
| Predictive Value of Tests | 2 | 2015 | 2301 | 0.030 |
Why?
|
| Telomere | 1 | 2017 | 231 | 0.030 |
Why?
|
| Cricetinae | 1 | 2015 | 398 | 0.030 |
Why?
|
| Repetitive Sequences, Nucleic Acid | 1 | 1996 | 373 | 0.030 |
Why?
|
| Proteins | 2 | 2012 | 1101 | 0.030 |
Why?
|
| Sensitivity and Specificity | 1 | 2020 | 2172 | 0.030 |
Why?
|
| Dexamethasone | 3 | 1988 | 282 | 0.030 |
Why?
|
| Hyaluronan Receptors | 1 | 1995 | 69 | 0.030 |
Why?
|
| Zebrafish Proteins | 1 | 2016 | 130 | 0.030 |
Why?
|
| Proto-Oncogene Proteins c-myc | 1 | 2016 | 218 | 0.030 |
Why?
|
| Disease Progression | 2 | 2011 | 2266 | 0.030 |
Why?
|
| Serine | 1 | 2015 | 185 | 0.030 |
Why?
|
| Hydrogen-Ion Concentration | 1 | 2015 | 470 | 0.030 |
Why?
|
| Germ-Line Mutation | 1 | 2017 | 370 | 0.030 |
Why?
|
| Hypoxia-Inducible Factor 1 | 1 | 2014 | 19 | 0.030 |
Why?
|
| Birt-Hogg-Dube Syndrome | 1 | 2014 | 6 | 0.030 |
Why?
|
| Japan | 1 | 2014 | 155 | 0.030 |
Why?
|
| Genes | 2 | 1988 | 450 | 0.030 |
Why?
|
| Glutamine | 1 | 2015 | 222 | 0.030 |
Why?
|
| HeLa Cells | 1 | 1996 | 838 | 0.030 |
Why?
|
| Treatment Outcome | 2 | 2011 | 13074 | 0.030 |
Why?
|
| Peroxisome Proliferator-Activated Receptor Gamma Coactivator 1-alpha | 1 | 2014 | 46 | 0.030 |
Why?
|
| Principal Component Analysis | 1 | 2014 | 160 | 0.030 |
Why?
|
| Chromosome Aberrations | 1 | 2017 | 628 | 0.030 |
Why?
|
| RNA, Long Noncoding | 1 | 2017 | 250 | 0.030 |
Why?
|
| Adaptation, Physiological | 1 | 2015 | 289 | 0.030 |
Why?
|
| Genome, Viral | 1 | 2014 | 185 | 0.030 |
Why?
|
| Telomerase | 1 | 2014 | 179 | 0.030 |
Why?
|
| Information Dissemination | 1 | 2016 | 199 | 0.030 |
Why?
|
| Hepatitis B virus | 1 | 2014 | 142 | 0.030 |
Why?
|
| Cell Survival | 1 | 2016 | 890 | 0.030 |
Why?
|
| Nerve Tissue Proteins | 1 | 2000 | 1167 | 0.030 |
Why?
|
| Mice, Knockout | 2 | 2014 | 4016 | 0.030 |
Why?
|
| Gene Expression Regulation | 3 | 1988 | 2669 | 0.030 |
Why?
|
| Basic Helix-Loop-Helix Transcription Factors | 1 | 2016 | 406 | 0.030 |
Why?
|
| CpG Islands | 1 | 2014 | 347 | 0.030 |
Why?
|
| Chromatin | 1 | 2017 | 617 | 0.030 |
Why?
|
| Gene Regulatory Networks | 1 | 2016 | 400 | 0.030 |
Why?
|
| DNA Repair | 1 | 2017 | 635 | 0.030 |
Why?
|
| Adenosine Triphosphate | 1 | 2014 | 298 | 0.030 |
Why?
|
| Receptors, Cytoplasmic and Nuclear | 1 | 2016 | 396 | 0.030 |
Why?
|
| Lymphocyte Activation | 1 | 1995 | 724 | 0.030 |
Why?
|
| Hepacivirus | 1 | 2014 | 273 | 0.020 |
Why?
|
| Image Processing, Computer-Assisted | 1 | 1995 | 616 | 0.020 |
Why?
|
| In Situ Nick-End Labeling | 1 | 2012 | 128 | 0.020 |
Why?
|
| Risk Factors | 2 | 2005 | 11182 | 0.020 |
Why?
|
| Survival Analysis | 1 | 2016 | 1599 | 0.020 |
Why?
|
| Rubinstein-Taybi Syndrome | 1 | 2012 | 17 | 0.020 |
Why?
|
| Blepharophimosis | 1 | 2012 | 26 | 0.020 |
Why?
|
| Smad4 Protein | 1 | 2012 | 58 | 0.020 |
Why?
|
| Models, Statistical | 1 | 2014 | 505 | 0.020 |
Why?
|
| Liver Neoplasms, Experimental | 2 | 1988 | 60 | 0.020 |
Why?
|
| Glucose Tolerance Test | 1 | 2012 | 227 | 0.020 |
Why?
|
| Metabolomics | 1 | 2015 | 470 | 0.020 |
Why?
|
| Bone Diseases, Developmental | 1 | 2012 | 61 | 0.020 |
Why?
|
| Muscle, Skeletal | 1 | 1998 | 1040 | 0.020 |
Why?
|
| Mice, Inbred BALB C | 2 | 2011 | 1089 | 0.020 |
Why?
|
| Codon | 1 | 2011 | 109 | 0.020 |
Why?
|
| Cyclin-Dependent Kinase Inhibitor p16 | 1 | 2012 | 118 | 0.020 |
Why?
|
| Twins, Dizygotic | 1 | 2011 | 48 | 0.020 |
Why?
|
| DNA Copy Number Variations | 1 | 2017 | 1034 | 0.020 |
Why?
|
| Glioma | 1 | 1996 | 540 | 0.020 |
Why?
|
| Protein Binding | 1 | 2015 | 1859 | 0.020 |
Why?
|
| Blepharoptosis | 1 | 2012 | 64 | 0.020 |
Why?
|
| Levodopa | 1 | 2011 | 94 | 0.020 |
Why?
|
| Gene Dosage | 1 | 2012 | 458 | 0.020 |
Why?
|
| Interdisciplinary Communication | 1 | 2011 | 135 | 0.020 |
Why?
|
| Drug Resistance, Neoplasm | 1 | 2015 | 825 | 0.020 |
Why?
|
| Cooperative Behavior | 1 | 2011 | 233 | 0.020 |
Why?
|
| Kaplan-Meier Estimate | 1 | 2012 | 1146 | 0.020 |
Why?
|
| Gene Frequency | 1 | 2011 | 779 | 0.020 |
Why?
|
| Heterozygote | 1 | 2012 | 728 | 0.020 |
Why?
|
| Carrier Proteins | 1 | 1995 | 1077 | 0.020 |
Why?
|
| Pancreatitis-Associated Proteins | 1 | 2009 | 15 | 0.020 |
Why?
|
| Ribonuclease, Pancreatic | 1 | 2009 | 22 | 0.020 |
Why?
|
| Blotting, Western | 1 | 2011 | 1140 | 0.020 |
Why?
|
| Organ Preservation Solutions | 1 | 2009 | 15 | 0.020 |
Why?
|
| Transforming Growth Factors | 1 | 1988 | 21 | 0.020 |
Why?
|
| Transcriptome | 1 | 2016 | 1138 | 0.020 |
Why?
|
| Quality Control | 1 | 2009 | 126 | 0.020 |
Why?
|
| Energy Metabolism | 1 | 2014 | 814 | 0.020 |
Why?
|
| Child, Preschool | 2 | 2020 | 14884 | 0.020 |
Why?
|
| Growth Substances | 1 | 1988 | 114 | 0.020 |
Why?
|
| Fluorescent Antibody Technique | 1 | 2009 | 434 | 0.020 |
Why?
|
| Confidentiality | 1 | 2009 | 106 | 0.020 |
Why?
|
| Specimen Handling | 1 | 2009 | 148 | 0.020 |
Why?
|
| Reproducibility of Results | 1 | 1995 | 3043 | 0.020 |
Why?
|
| Genes, Regulator | 1 | 1988 | 57 | 0.020 |
Why?
|
| Cell Cycle | 1 | 2010 | 628 | 0.020 |
Why?
|
| Cerebellum | 1 | 2012 | 467 | 0.020 |
Why?
|
| HEK293 Cells | 1 | 2010 | 825 | 0.020 |
Why?
|
| Transplantation, Heterologous | 1 | 2008 | 276 | 0.020 |
Why?
|
| Neovascularization, Pathologic | 1 | 2009 | 263 | 0.020 |
Why?
|
| Algorithms | 1 | 2014 | 1736 | 0.020 |
Why?
|
| Texas | 1 | 2016 | 3716 | 0.020 |
Why?
|
| Transforming Growth Factor beta | 1 | 1990 | 488 | 0.020 |
Why?
|
| Down-Regulation | 1 | 2009 | 720 | 0.020 |
Why?
|
| Informed Consent | 1 | 2009 | 345 | 0.020 |
Why?
|
| Receptors, Interleukin-2 | 2 | 1996 | 44 | 0.020 |
Why?
|
| Enhancer Elements, Genetic | 1 | 1988 | 322 | 0.020 |
Why?
|
| Lymphokines | 2 | 1996 | 69 | 0.020 |
Why?
|
| Decision Making | 1 | 2011 | 701 | 0.020 |
Why?
|
| Antibodies, Monoclonal | 1 | 2011 | 1072 | 0.010 |
Why?
|
| Fetus | 1 | 1988 | 601 | 0.010 |
Why?
|
| Killer Cells, Natural | 1 | 1987 | 357 | 0.010 |
Why?
|
| Neoplasm Recurrence, Local | 1 | 2011 | 1317 | 0.010 |
Why?
|
| Child | 2 | 2020 | 25890 | 0.010 |
Why?
|
| Liver Cirrhosis | 1 | 2011 | 947 | 0.010 |
Why?
|
| Computational Biology | 1 | 2009 | 890 | 0.010 |
Why?
|
| Genome-Wide Association Study | 1 | 2011 | 1880 | 0.010 |
Why?
|
| Precipitin Tests | 1 | 2002 | 158 | 0.010 |
Why?
|
| Prevalence | 1 | 2009 | 2684 | 0.010 |
Why?
|
| Hormones | 1 | 1983 | 198 | 0.010 |
Why?
|
| Cell Size | 1 | 2002 | 90 | 0.010 |
Why?
|
| Recurrence | 1 | 2005 | 1472 | 0.010 |
Why?
|
| Prednisolone | 1 | 1981 | 79 | 0.010 |
Why?
|
| Tyrosine | 1 | 2002 | 161 | 0.010 |
Why?
|
| Immunoblotting | 1 | 2002 | 319 | 0.010 |
Why?
|
| Disease Models, Animal | 1 | 2012 | 4808 | 0.010 |
Why?
|
| Genes, Reporter | 1 | 2002 | 398 | 0.010 |
Why?
|
| Microscopy, Confocal | 1 | 2002 | 367 | 0.010 |
Why?
|
| Transcriptional Activation | 2 | 1995 | 504 | 0.010 |
Why?
|
| Heart Defects, Congenital | 1 | 2012 | 1884 | 0.010 |
Why?
|
| Time Factors | 1 | 1990 | 6610 | 0.010 |
Why?
|
| Cell Membrane | 1 | 2002 | 489 | 0.010 |
Why?
|
| Mice, Inbred C3H | 2 | 1990 | 123 | 0.010 |
Why?
|
| Rats | 4 | 1988 | 3890 | 0.010 |
Why?
|
| Recombinant Fusion Proteins | 1 | 2002 | 806 | 0.010 |
Why?
|
| Creatine Kinase | 1 | 1998 | 64 | 0.010 |
Why?
|
| beta-Galactosidase | 1 | 1998 | 151 | 0.010 |
Why?
|
| Phosphorylation | 1 | 2002 | 1713 | 0.010 |
Why?
|
| Lewis X Antigen | 1 | 1996 | 11 | 0.010 |
Why?
|
| L-Selectin | 1 | 1996 | 22 | 0.010 |
Why?
|
| Genes, Immunoglobulin | 1 | 1996 | 33 | 0.010 |
Why?
|
| Models, Biological | 1 | 2002 | 1539 | 0.010 |
Why?
|
| Albumins | 2 | 1988 | 99 | 0.010 |
Why?
|
| Behavior, Animal | 1 | 1998 | 522 | 0.010 |
Why?
|
| Integrin alpha1beta1 | 1 | 1994 | 4 | 0.010 |
Why?
|
| Immunophenotyping | 1 | 1995 | 344 | 0.010 |
Why?
|
| Immunoenzyme Techniques | 1 | 1994 | 258 | 0.010 |
Why?
|
| DNA Replication | 2 | 1988 | 366 | 0.010 |
Why?
|
| Cell Line, Transformed | 1 | 1990 | 169 | 0.010 |
Why?
|
| Receptors, Transforming Growth Factor beta | 1 | 1990 | 107 | 0.000 |
Why?
|
| Platelet-Derived Growth Factor | 1 | 1988 | 45 | 0.000 |
Why?
|
| Cell Fusion | 1 | 1988 | 38 | 0.000 |
Why?
|
| Tyrosine Transaminase | 1 | 1988 | 12 | 0.000 |
Why?
|
| Chloramphenicol O-Acetyltransferase | 1 | 1988 | 80 | 0.000 |
Why?
|
| Epidermal Growth Factor | 1 | 1988 | 123 | 0.000 |
Why?
|
| Enzyme Induction | 1 | 1988 | 105 | 0.000 |
Why?
|
| Protein Kinases | 1 | 1990 | 345 | 0.000 |
Why?
|
| Cytosol | 1 | 1988 | 169 | 0.000 |
Why?
|
| Fibroblast Growth Factors | 1 | 1988 | 163 | 0.000 |
Why?
|
| Lung | 1 | 1994 | 1577 | 0.000 |
Why?
|
| Medroxyprogesterone | 1 | 1983 | 8 | 0.000 |
Why?
|
| Methionine | 1 | 1983 | 105 | 0.000 |
Why?
|
| Rats, Inbred Strains | 1 | 1981 | 236 | 0.000 |
Why?
|
| Serum Albumin | 1 | 1981 | 117 | 0.000 |
Why?
|